Montreal, Canada

Eric Bonneil

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Universitéde Montreal. Active years: 2015.



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eric Bonneil: Innovator in Protein SUMOylation Research

Introduction

Eric Bonneil is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of molecular biology, particularly in the study of protein SUMOylation. His innovative work has led to the development of a patented technology that enhances our understanding of protein interactions within mammalian cells.

Latest Patents

Eric Bonneil holds a patent for "Mutated SUMO isoforms and uses thereof." This patent discloses substantially pure nucleic acids encoding mutated SUMO isoforms, polypeptides, vectors, cells, and methods for identifying and quantifying protein SUMOylation in mammalian cells. Additionally, it introduces a dual affinity method for detecting a mutated SUMOylated protein substrate fragment. This invention represents a significant advancement in the field of protein research.

Career Highlights

Eric Bonneil is affiliated with the Université de Montréal, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential applications in understanding cellular processes and disease mechanisms.

Collaborations

Eric collaborates with esteemed colleagues, including Louiza Mahrouche and Sylvain Meloche. Their combined expertise enhances the research output and fosters innovation in their respective fields.

Conclusion

Eric Bonneil's contributions to the field of protein SUMOylation through his patented innovations highlight his role as a leading inventor in molecular biology. His work not only advances scientific knowledge but also opens new avenues for research and application in the life sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…